Trial description:
Microbiome Immunotherapy Toxicity and Response Evaluation (MITRE) An observational study to evaluate the microbiome as a biomarker of efficacy and toxicity in cancer patients receiving immune checkpoint inhibitor therapy
Contact name:
Dr Pippa Corrie
Trial start date:
Tuesday, March 30, 2021
Trial end date:
Tuesday, July 8, 2025
Trial tumour type:
Lung
Kidney
Skin & melanoma
Show on Radiotherapy:
No
